CSI HAMBURG

EMEA/CHMP/BMWP/14327/2006 Rev.1: Guideline on immunogenicity assessment of biotechnology-derived therapeutic proteins (mandatory);... EMEA/CHMP/QWP/251344/2006: Guideline on the limits of genotoxic impurities (optional);... EMEA/CHMP/28367/07 Rev.1: Guideline on strategies to identify and mitigate risk for first-in-human and early clinical trials with investigational medicine products (mandatory);

Also known as: CSi Hamburg GmbH

Registration numbers: HRB 127764 (W)

Primary location: Hamburg Germany